{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T15:23:42Z","timestamp":1795101822752,"version":"4.10.3"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>The clinical components of the predicting renal outcome in polycystic kidney disease score are a strong predictor of progression in these Black African patients.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Ultrasound-measured kidney length was useful, but further calibration and standardization may be needed in this population<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Risk stratification in autosomal dominant polycystic kidney disease (ADPKD) is essential for selecting candidates for disease-modifying therapies. However, established prognostic tools such as the Mayo Imaging Classification and Predicting Renal Outcome in Polycystic Kidney Disease (PROPKD) score rely on magnetic resonance imaging and genotyping, which are often unavailable in resource-limited settings. Furthermore, these tools lack validation in African populations. We evaluated the utility of pragmatic, accessible prognostic markers in a multiethnic South African cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective cohort study of 276 adults with ADPKD, we assessed 2 prognostic tools: a modified PROPKD score (range 0\u20135; derived solely from age, sex, hypertension, and urological events, excluding genotype) and ultrasound-measured kidney length. The primary outcome was progression to ESKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This was an ethnically diverse population (54% Black, 33% Indian\/Asian, 8% White), mostly female patients. In multivariable Cox regression, the modified clinical PROPKD score strongly predicted ESKD (high-risk category: hazard ratio, 4.34; 95% confidence interval, 2.88 to 6.71;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), as did kidney length &gt;16.5 cm (hazard ratio, 1.87; 95% confidence interval, 1.32 to 2.64;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). The modified clinical PROPKD score demonstrated moderate discriminative ability (area under the curve [AUC], 0.66), numerically outperforming kidney length (AUC, 0.61). The score's predictive performance was highest in Black patients (AUC, 0.76) compared with White patients (AUC, 0.51).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A modified PROPKD score was an independent predictor of ADPKD progression. Its superior performance in Black African patients supports that clinical phenotypes, particularly early-onset hypertension, are potent markers of disease severity in this demographic.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.34067\/kid.0000001357","type":"journal-article","created":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:00:38Z","timestamp":1793757638000},"page":"2528-2535","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Validation of Prognostic Tools for Autosomal Dominant Polycystic Kidney Disease Progression in a Multiethnic South African Cohort"],"prefix":"10.34067","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2730-7363","authenticated-orcid":false,"given":"Cedric Xavier M.","family":"Kapche","sequence":"first","affiliation":[{"name":"Department of Nephrology, Nelson Mandela School of Medicine, South Africa"},{"name":"Renal Unit, Inkosi Albert Luthuli Central Hospital, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Assounga","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nelson Mandela School of Medicine, South Africa"},{"name":"Renal Unit, Inkosi Albert Luthuli Central Hospital, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"issue":"10174","key":"B1-20261119","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease","volume":"393","author":"Cornec-Le Gall","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"B2-20261119","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.ajkd.2020.12.020","article-title":"Assessing risk of rapid progression in autosomal dominant polycystic kidney disease and special considerations for disease-modifying therapy","volume":"78","author":"Chebib","year":"2021","journal-title":"Am J Kidney Dis."},{"issue":"5","key":"B3-20261119","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2215\/CJN.02320220","article-title":"Insights into autosomal dominant polycystic kidney disease from genetic studies","volume":"16","author":"Lanktree","year":"2021","journal-title":"Clin J Am Soc Nephrol."},{"issue":"7","key":"B4-20261119","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ekir.2019.04.018","article-title":"Intrafamilial variability of ADPKD","volume":"4","author":"Lanktree","year":"2019","journal-title":"Kidney Int Rep."},{"issue":"1","key":"B5-20261119","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"26","author":"Irazabal","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B6-20261119","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int."},{"issue":"2","key":"B7-20261119","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.kint.2024.07.010","article-title":"KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary","volume":"107","author":"Torres","year":"2025","journal-title":"Kidney Int."},{"issue":"1","key":"B8-20261119","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"B9-20261119","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1681\/ASN.2015010016","article-title":"The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease","volume":"27","author":"Cornec-Le Gall","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"B10-20261119","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000502634","article-title":"Comparison of different selection strategies for Tolvaptan eligibility among autosomal dominant polycystic kidney disease patients","volume":"50","author":"Wulfmeyer","year":"2019","journal-title":"Am J Nephrol."},{"issue":"5","key":"B11-20261119","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41431-020-00796-4","article-title":"Genomic diagnostics in polycystic kidney disease: an assessment of real-world use of whole-genome sequencing","volume":"29","author":"Mallawaarachchi","year":"2021","journal-title":"Eur J Hum Genet."},{"issue":"1","key":"B12-20261119","doi-asserted-by":"crossref","first-page":"2492374","DOI":"10.1080\/0886022X.2025.2492374","article-title":"Autosomal dominant polycystic kidney disease: an overview of recent genetic and clinical advances","volume":"47","author":"Borghol","year":"2025","journal-title":"Renal Fail."},{"issue":"6","key":"B13-20261119","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1681\/ASN.2015060648","article-title":"Refining genotype-phenotype correlation in autosomal dominant polycystic kidney disease","volume":"27","author":"Hwang","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"B14-20261119","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/ijn.ijn_69_22","article-title":"Predicting the risk of progression in Indian ADPKD cohort using PROPKD score \u2013 a single-center retrospective study","volume":"33","author":"Sreenidhi","year":"2023","journal-title":"Indian J Nephrol."},{"issue":"5","key":"B15-20261119","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s40620-025-02282-w","article-title":"Comparative validation of the Mayo clinic imaging classification and PROPKD score for predicting ADPKD progression across diverse ethnic cohorts","volume":"38","author":"Caliskan","year":"2025","journal-title":"J Nephrol."},{"issue":"1","key":"B16-20261119","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12882-019-1241-1","article-title":"Revisiting racial differences in ESRD due to ADPKD in the United States","volume":"20","author":"Murphy","year":"2019","journal-title":"BMC Nephrol."},{"issue":"7","key":"B17-20261119","doi-asserted-by":"crossref","first-page":"976","DOI":"10.2215\/CJN.00840122","article-title":"Health disparities in autosomal dominant polycystic kidney disease (ADPKD) in the United States","volume":"17","author":"McGill","year":"2022","journal-title":"Clin J Am Soc Nephrol."},{"issue":"1","key":"B18-20261119","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0272-6386(00)70298-8","article-title":"Racial variation in autosomal dominant polycystic kidney disease","volume":"35","author":"Freedman","year":"2000","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B19-20261119","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ki.2015.71","article-title":"A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease","volume":"88","author":"Bhutani","year":"2015","journal-title":"Kidney Int."},{"issue":"2","key":"B20-20261119","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4103\/jmu.jmu_77_23","article-title":"Update on the application of ultrasonography in understanding autosomal dominant polycystic kidney disease","volume":"32","author":"Lee","year":"2024","journal-title":"J Med Ultrasound."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000001357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T15:01:00Z","timestamp":1795100460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000001357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000001357","relation":{},"ISSN":["2641-7650","2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"},{"value":"2641-7650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"2026-02-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}